v3.24.3
Insider Trading Arrangements
3 Months Ended 9 Months Ended
Oct. 27, 2024
shares
Oct. 27, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Non-Rule 10b5-1 Arrangement Terminated false  
David Reeder [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On September 11, 2024, David Reeder, the Company’s Chief Financial Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K in the form of a “sell-to-cover” instruction of indefinite duration to instruct the Company to sell shares of Class A common stock to satisfy tax withholding obligations arising from the vesting of RSUs. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The number of shares that will be sold under the arrangement is not currently determinable as the number will vary based on the extent to which vesting conditions are satisfied and the market price of our Class A common stock at the time of settlement.
On October 6, 2024, David Reeder, the Company’s Chief Financial Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 581,251 shares.
Arrangement Duration 451 days  
William Billings [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On September 11, 2024, William Billings, the Company’s Chief Accounting Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K in the form of a “sell-to-cover” instruction of indefinite duration to instruct the Company to sell shares of Class A common stock to satisfy tax withholding obligations arising from the vesting of RSUs. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The number of shares that will be sold under the arrangement is not currently determinable as the number will vary based on the extent to which vesting conditions are satisfied and the market price of our Class A common stock at the time of settlement.
Name William Billings  
Title Chief Accounting Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date September 11, 2024  
Aseemita Malhotra [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On September 19, 2024, Aseemita Malhotra, the Company's President of Chewy Health, and spouse of the Company's Chief Executive Officer, Sumit Singh, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 142,322 shares.
Name Aseemita Malhotra  
Title President of Chewy Health  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date September 19, 2024  
Expiration Date December 31, 2025  
Arrangement Duration 468 days  
Aggregate Available 142,322 142,322
Sumit Singh [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On September 25, 2024, Sumit Singh, the Company’s Chief Executive Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 1,387,271 shares.
Name Sumit Singh  
Title Chief Executive Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date September 25, 2024  
Expiration Date December 31, 2025  
Arrangement Duration 462 days  
Aggregate Available 1,387,271 1,387,271
Satish Mehta [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On October 2, 2024, Satish Mehta, the Company’s Chief Technology Officer, terminated the “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K that he had previously adopted on July 12, 2024. On October 6, 2024, Satish Mehta adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 541,328 shares.
Name Satish Mehta  
Title Chief Technology Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date October 6, 2024  
Rule 10b5-1 Arrangement Terminated true  
Termination Date October 2, 2024  
Expiration Date December 31, 2025  
Arrangement Duration 451 days  
Aggregate Available 541,328 541,328
David Reeder September 2024 Plan [Member] | David Reeder [Member]    
Trading Arrangements, by Individual    
Name David Reeder  
Title Chief Financial Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date September 11, 2024  
David Reeder October 2024 Plan [Member] | David Reeder [Member]    
Trading Arrangements, by Individual    
Name David Reeder  
Title Chief Financial Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date October 6, 2024  
Expiration Date December 31, 2025  
Aggregate Available 581,251 581,251